Haemangiosarcoma in the horse
Authors: Taintor J.
Journal: Equine Veterinary Education
Summary
Haemangiosarcoma represents a rare but aggressive malignancy of vascular endothelial origin in horses, presenting either as localised masses (commonly affecting the eye or skin) or as disseminated disease across multiple organs. Because clinical signs are largely non-specific—ranging from visible swelling to organ dysfunction—differentiation from other neoplasms proves challenging, and ante mortem diagnosis via cytology or fine needle aspiration frequently yields inconclusive results. Biopsy with histopathological examination, sometimes requiring immunohistochemical staining to confirm diagnosis, remains the most reliable diagnostic approach, though notably the majority of cases are identified only at post mortem examination. Middle-aged horses appear most commonly affected, with no apparent sex or breed predilection noted in available case reports. Prognosis is uniformly poor given the tumour's aggressive biological behaviour and limited treatment options based on mass location, making early recognition and thorough investigation of any suspicious vascular lesion critical for clinicians managing equine neoplasia.
Read the full abstract on the publisher's site
Practical Takeaways
- •Suspect haemangiosarcoma in middle-aged horses presenting with unexplained vascular masses or organ dysfunction, but be aware diagnosis is challenging without histopathology
- •Biopsy or mass submission for histopathological examination (potentially with immunohistochemical staining) is necessary for definitive diagnosis
- •Prognosis is poor; focus management on palliative care and owner counselling rather than expecting curative treatment options
Key Findings
- •Haemangiosarcoma is rare in horses and can present as solitary masses (typically eye or skin) or as disseminated tumours across multiple organs
- •Clinical presentation is variable and non-specific, making differentiation from other neoplasms difficult
- •Ante mortem diagnosis is often unrewarding; majority of cases are diagnosed post mortem
- •Treatment options are limited and often unrewarding due to tumour location and aggressive nature